Cargando…
Pathogenesis of COVID-19-associated mucormycosis (CAM) in India: probing the triggering factors
Autores principales: | Arakeri, Gururaj, Patil, Shreyas, Rao US, Vishal, Amaral Mendes, Rui, Oeppen, Rachel S, Brennan, Peter A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Ltd on behalf of The British Association of Oral and Maxillofacial Surgeons.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8591848/ https://www.ncbi.nlm.nih.gov/pubmed/35351328 http://dx.doi.org/10.1016/j.bjoms.2021.10.018 |
Ejemplares similares
-
COVID-associated mucormycosis (CAM): is the Delta variant a cause?
por: Arakeri, Gururaj, et al.
Publicado: (2022) -
COVID-19 associated mucormycosis (CAM) in India: a formidable challenge
por: Rao, Vishal U.S., et al.
Publicado: (2021) -
Does Yadgir population have copper-mediated intrinsic immunity to resist COVID-19 challenge?
por: Patil, Shekar, et al.
Publicado: (2021) -
Methylene blue as an anti-COVID-19 mouthwash in dental practice
por: Arakeri, Gururaj, et al.
Publicado: (2021) -
Decreased Cancer Consultations in the COVID-19 Era: A Concern for Delay in Early Cancer Diagnosis in India
por: Rao, Vishal, et al.
Publicado: (2021)